CelLBxHealth PLC (AIM:CLBX, FRA:DWV) jumped 6% after a new study showed its Parsortix system can spot cancer drug targets in blood samples. It even caught targets that rival tests would've missed completely.
Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has dosed its first US patient with a reworked version of its cancer drug AO-252. The new capsule fixes an absorption problem and no safety issues have shown up yet.
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) got fast-tracked examination from the US patent office for its longevity gene variant. It's also had a second patent published covering fatty liver disease treatment.
Bradda Head Lithium Ltd (AIM:BHL) found surface samples grading up to 4.24% lithium oxide at its Whistlejacket project in Arizona. That's boosted confidence in drill targets ahead of next year's programme.
Quantum Helium Ltd (AIM:QHE) has picked out two near-term drilling targets in Colorado after finishing its seismic work. They could be drilled within a year and might kickstart production and cash flow.
Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) says its AI mining software is showing a consistent edge after being adapted for a manufacturer's rig. It's now working on compressing the software to run directly on that hardware.
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.
